Back
United Therapeutics Corp. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49
UTHR
United Therapeutics Corp.
Last Price:
$480.60
Seasonality Move:
-0.46%
7 Day Trial
ALL ACCESS PASS
$
7
United Therapeutics Corp. Stock Forecast
-
Over the next 52 weeks, United Therapeutics Corp. has on average historically risen by 20.4% based on the past 26 years of stock performance.
-
United Therapeutics Corp. has risen higher in 16 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.54%
-
Is United Therapeutics Corp. Stock Undervalued?The current United Therapeutics Corp. [UTHR] share price is $476.05. The Score for UTHR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
UTHR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will United Therapeutics Corp. Stock Go Up Next Year?
-
Over the next 52 weeks, United Therapeutics Corp. has on average historically risen by 20.4% based on the past 26 years of stock performance.
United Therapeutics Corp. Stock Rating
Sell
49
United Therapeutics Corp. (UTHR)
is a Sell
Is United Therapeutics Corp. overpriced?
-
United Therapeutics Corp. has risen higher in 16 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.54%
United Therapeutics Corp. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
unither.com
52-Week Data
52-Week High:
519.99
52-Week Low:
266.98
Prediction Charts
Market Cap:
20.5B
Price in USD:
476.05
Volume:
218K
Beta:
0.54
Technical Analysis
SMA50:
485.66
SMA100:
468.09
SMA200:
393.63
52-Wk Change:
27.69%
Stock Predictions
-
Is United Therapeutics Corp. stock public?Yes, United Therapeutics Corp. is a publicly traded company.
-
What is the United Therapeutics Corp. stock quote today?The United Therapeutics Corp. stock price is 476.05 USD today.
-
How to buy United Therapeutics Corp. stock online?You can buy United Therapeutics Corp. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-29 | 466.78 | 467.70 | 472.41 | 465.50 |
| Jan-30 | 465.71 | 469.49 | 470.87 | 462.02 |
| Feb-2 | 467.17 | 475.00 | 475.65 | 466.01 |
| Feb-3 | 474.23 | 478.27 | 480.86 | 470.83 |
| Feb-4 | 481.97 | 482.59 | 487.50 | 472.51 |
| Feb-5 | 480.66 | 478.93 | 487.33 | 476.95 |
| Feb-6 | 483.81 | 485.36 | 489.50 | 481.95 |
| Feb-9 | 486.15 | 473.12 | 486.25 | 469.69 |
| Feb-10 | 475.01 | 473.20 | 475.69 | 468.62 |
| Feb-11 | 474.65 | 475.85 | 475.85 | 464.44 |
| Feb-12 | 475.45 | 476.13 | 479.14 | 469.83 |
| Feb-13 | 478.90 | 473.66 | 484.98 | 471.00 |
| Feb-17 | 474.68 | 482.42 | 486.33 | 470.04 |
| Feb-18 | 478.96 | 476.05 | 481.70 | 472.48 |
United Therapeutics Corp. Earnings
United Therapeutics Corp. Earnings Report: Per Share United Therapeutics Corp. Earnings Q1 Q2 Q3 and Q4 last year and next year.
United Therapeutics Corp. Forecast Revenue Growth
United Therapeutics Corp. Stock Analysis: Historical quarterly revenues per share for United Therapeutics Corp. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.80 per share, and an increase next year of $1.57 per share.
* United Therapeutics Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.